Dr. Reddy's Laboratories Limited — Important, 07-01-2025: General Updates

Dr. Reddy’s Laboratories Inc., a wholly owned subsidiary of Dr. Reddy’s Laboratories Limited, has finalized an agreement to sell its subsidiary, Dr. Reddy’s Laboratories Louisiana LLC (DRLL), along with its manufacturing facility in Shreveport, Louisiana. The deal reflects a turnover contribution of USD 38.91 million, approximately 0.68% of the company’s consolidated income, and a net worth of USD 29.49 million, about 0.47% of consolidated net worth, as per the last audited financial statements. The transaction, which is not deemed a related party transaction, is expected to be completed by March 18, 2025, with a minimal consideration of USD 1. This facility is considered non-strategic for Dr. Reddy’s, with no future product pipeline. The sale could streamline operations, reducing overheads and redirecting focus to more critical areas, hence a positive outlook for operational efficiency.